Literature DB >> 6738811

Prolactin-induced activation of tuberoinfundibular dopaminergic neurons: evidence for both a rapid 'tonic' and a delayed 'induction' component.

K T Demarest, G D Riegle, K E Moore.   

Abstract

Results of previous studies have revealed that prolactin causes a delayed (12-16 h) increase in the rate of synthesis and turnover of dopamine (DA) in terminals of tuberoinfundibular (TI) neurons in the median eminence. Attempts to demonstrate a rapid in vivo action of prolactin on these neurons has been frustrated because pharmacological manipulations needed to make the biochemical measurements of TIDA neuronal activity (i.e., administration of alpha-methyltyrosine or NSD 1015) inhibit DA synthesis and thereby remove the tonic inhibitory control of DA on prolactin secretion. Thus, 'control' rates of synthesis and turnover of DA in terminals of TIDA neurons are actually values obtained in the presence of high circulating concentrations of prolactin. Results of the present in vivo studies demonstrate that there are two components to the activation of TIDA neurons by prolactin: a rapid 'tonic' component, which is responsive to acute changes in prolactin concentrations, and a delayed 'induction' component, which is activated by long-term changes in prolactin concentrations. Experimental observations which support this proposal are described below. Hypophysectomy or treatment with bromocriptine (a DA agonist) reduce circulating levels of prolactin and reduce the rate of DA synthesis in the median eminence. Intracerebroventricular (i.c.v.) administration of prolactin to these animals increases the rate of DA synthesis in the median eminence within 4 h (rapid 'tonic' component) and then causes a further increase after 12 h (delayed 'induction' component); only the latter component is blocked by treatment with cycloheximide, indicating the involvement in protein synthesis.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6738811     DOI: 10.1159/000123935

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  12 in total

Review 1.  A tale of two rhythms: the emerging roles of oxytocin in rhythmic prolactin release.

Authors:  R Bertram; C V Helena; A E Gonzalez-Iglesias; J Tabak; M E Freeman
Journal:  J Neuroendocrinol       Date:  2010-04-29       Impact factor: 3.627

2.  Effects of the antidopaminergic drug veralipride on LH and PRL secretion in postmenopausal women.

Authors:  P Fioretti; A Cagnacci; A M Paoletti; M Gambacciani; R Soldani; G A Mauro; A Spinetti; G B Melis
Journal:  J Endocrinol Invest       Date:  1989-05       Impact factor: 4.256

Review 3.  Dopamine: Functions, Signaling, and Association with Neurological Diseases.

Authors:  Marianne O Klein; Daniella S Battagello; Ariel R Cardoso; David N Hauser; Jackson C Bittencourt; Ricardo G Correa
Journal:  Cell Mol Neurobiol       Date:  2018-11-16       Impact factor: 5.046

4.  Regulation of cytokine-inducible SH2-containing protein (CIS) by ubiquitination and Elongin B/C interaction.

Authors:  Philip J Jensik; Lydia A Arbogast
Journal:  Mol Cell Endocrinol       Date:  2014-11-04       Impact factor: 4.102

5.  Prolactin replacement must be continuous and initiated prior to 21 d of age to maintain hypothalamic dopaminergic neurons in hypopituitary mice.

Authors:  Carol J Phelps; Mario I Romero; David L Hurley
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

6.  Hypoprolactinemia decreases tyrosine hydroxylase activity in the tuberoinfundibular dopaminergic neurons acutely by protein dephosphorylation and chronically by changes in gene expression.

Authors:  L A Arbogast; J L Voogt
Journal:  Endocrine       Date:  1995-11       Impact factor: 3.633

7.  Decreased expression of fos-related antigens (FRAs) in the hypothalamic dopaminergic neurons after immunoneutralization of endogenous prolactin.

Authors:  A A Lerant; J E DeMaria; M E Freeman
Journal:  Endocrine       Date:  2001-12       Impact factor: 3.633

8.  Differential effects of haloperidol, clozapine, and fluperlapine on tuberoinfundibular dopamine neurons and prolactin secretion in the rat.

Authors:  G A Gudelsky; J I Koenig; M Simonovic; T Koyama; T Ohmori; H Y Meltzer
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

9.  Timed bromocriptine administration reduces body fat stores in obese subjects and hyperglycemia in type II diabetics.

Authors:  A H Meier; A H Cincotta; W C Lovell
Journal:  Experientia       Date:  1992-03-15

Review 10.  The role of prolactin in andrology: what is new?

Authors:  Giulia Rastrelli; Giovanni Corona; Mario Maggi
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.